We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

217 hedge funds and large institutions have $922M invested in Immunogen Inc in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 74 increasing their positions, 64 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

318% more call options, than puts

Call options by funds: $7.09M | Put options by funds: $1.7M

16% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 64

8% less funds holding

Funds holding: 236217 (-19)

33% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 43

34% less capital invested

Capital invested by funds: $1.41B → $922M (-$484M)

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

Holders
217
Holders Change
-19
Holders Change %
-8.05%
% of All Funds
3.42%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
29
Increased
74
Reduced
64
Closed
43
Calls
$7.09M
Puts
$1.7M
Net Calls
+$5.4M
Net Calls Change
+$404K
Name Holding Trade Value Shares
Change
Change in
Stake
Northwestern Mutual Wealth Management
176
Northwestern Mutual Wealth Management
Wisconsin
$12K -$293 -53 -2%
WTA
177
Washington Trust Advisors
Massachusetts
$11K -$1.06K -191 -8%
LSA
178
Leonteq Securities AG
Switzerland
$10.2K
CAPTRUST Financial Advisors
179
CAPTRUST Financial Advisors
North Carolina
$10K
National Bank of Canada
180
National Bank of Canada
Quebec, Canada
$10K
WWM
181
Wolff Wiese Magana
California
$9K
Koshinski Asset Management
182
Koshinski Asset Management
Illinois
$7.72K -$111 -20 -1%
Rockefeller Capital Management
183
Rockefeller Capital Management
New York
$6K +$1.06K +192 +15%
LJHT
184
Laurie J. Hall Trustee
$5K
HPC
185
HM Payson & Co
Maine
$4K
KFI
186
Key Financial Inc
Pennsylvania
$4K
SCM
187
Silverarc Capital Management
Massachusetts
$3.07K -$4.81M -869,411 -57%
IFAM
188
Institutional & Family Asset Management
Colorado
$3K -$133 -24 -3%
Daiwa Securities Group
189
Daiwa Securities Group
Japan
$3K
WTC
190
WhitTier Trust Company
Nevada
$3K
PFS
191
Prospera Financial Services
Texas
$3K +$3K +541 New
PWMG
192
Prestige Wealth Management Group
New Jersey
$2K
BBHC
193
Brown Brothers Harriman & Co
New York
$1K -$125K -22,500 -99%
Carson Wealth (CWM LLC)
194
Carson Wealth (CWM LLC)
Nebraska
$1K -$39 -7 -4%
CWC
195
Carolinas Wealth Consulting
North Carolina
$1K
CA
196
Centerpoint Advisors
Massachusetts
$1K
FWM
197
Focused Wealth Management
New York
$1K
IA
198
IFP Advisors
Florida
$1K
S
199
SignatureFD
Georgia
$1K
ZIG
200
Zullo Investment Group
Pennsylvania
$1K

IMGN Hedge Fund Activity: Q1 2022 in Review

217 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2022, worth a combined $922M — down 34% from $1.41B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of IMGN and 29 opened new positions — a net loss of 14 holders — while 64 trimmed existing stakes and 74 added.

The largest buyer was State Street, adding an estimated $31.2M. The largest seller was OrbiMed, exiting entirely with an estimated $28.7M sold.

  • 217 institutional investors held Immunogen Inc (IMGN) as of Q1 2022, down from 236 in Q4 2021.
  • Funds reported $922M of Immunogen Inc stock for Q1 2022, down 34% quarter-over-quarter.
  • 29 funds opened new Immunogen Inc positions in Q1 2022 and 43 closed out, a net change of -14 holders.
  • The largest Immunogen Inc buyer in Q1 2022 was State Street, an estimated $31.2M added.
  • The largest Immunogen Inc seller in Q1 2022 was OrbiMed, an estimated $28.7M sold.

Based on aggregated 13F filings for Q1 2022.